Nathan Frebeck
Analyst, Wells Fargo
Replay available
LeMaitre Vascular, Inc. (NASDAQ: LMAT) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Analyst, Wells Fargo
Analyst, Barrington Research
Analyst, Freedom Capital Markets
Analyst, Lake Street Capital Markets
Analyst, Citizens JMB
Chief Financial Officer
Analyst, Sidoti & Company
Analyst, Jefferies
Watch the replay and follow the connected company analysis, news, and investor updates for Lemaitre Vascular, Inc..
WEBVTT 00:00:00.031 -- 00:00:03.455 Welcome to the Lumate Vascular Q1 2026 00:00:03.455 -- 00:00:08.521 Financial Results Conference Call. As a reminder to everyone, today's call 00:00:08.521 -- 00:00:13.427 is being recorded. At this time, I would like to turn the call over to Mr. 00:00:13.427 -- 00:00:17.913 Dorian LeBlanc, Chief Financial Officer of Lumate Vascular. 00:00:17.913 -- 00:00:20.654 Please go ahead, sir. 00:00:22.178 -- 00:00:24.020 Thank you. 00:00:24.020 -- 00:00:28.364 Good afternoon, and thank you for joining us on our Q1 2026 Conference Call. 00:00:28.364 -- 00:00:33.349 With me on today's call is our CEO, George LeMaitre, and our President, Dave Roberts. 00:00:33.349 -- 00:00:36.932 Before we begin, I'll read our Safe Harbor Statement. 00:00:36.932 -- 00:00:40.175 Today we'll be making some forward-looking statements within the meaning of the U.S. 00:00:40.175 -- 00:00:44.920 Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to 00:00:44.920 -- 00:00:49.044 risks and uncertainties. Wherever possible, we will try to identify those forward-looking 00:00:49.044 -- 00:00:54.068 statements by using words such as believe, expect, anticipate, pursue, 00:00:54.068 -- 00:00:58.418 forecast, and similar expressions. Our forward-looking statements are based on our estimates 00:00:58.418 -- 00:01:03.625 and assumptions as of today, May 5, 2026, and should not be relied upon as representing 00:01:03.625 -- 00:01:06.369 our estimates or views on any subsequent date. 00:01:06.369 -- 00:01:09.514 Please refer to the cautionary statement regarding forward-looking information and the 00:01:09.514 -- 00:01:14.601 risk factors in our most recent 10-K and subsequent SEC filings, including disclosures 00:01:14.601 -- 00:01:19.348 of fac...